Immature platelet fraction in rheumatoid arthritis with interstitial lung disease.

[1]  E. Kang,et al.  Lung Involvements in Rheumatic Diseases: Update on the Epidemiology, Pathogenesis, Clinical Features, and Treatment , 2018, BioMed research international.

[2]  P. Sarzi-Puttini,et al.  Interstitial lung disease in systemic autoimmune rheumatic diseases: a comprehensive review , 2018, Expert review of clinical immunology.

[3]  H. Staub,et al.  Mean Platelet Volume and Immature Platelet Fraction in Autoimmune Disorders , 2017, Front. Med..

[4]  A. Zink,et al.  Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies , 2017, Arthritis Research & Therapy.

[5]  E. Passegué,et al.  The lung is a site of platelet biogenesis and a reservoir for hematopoietic progenitors , 2017, Nature.

[6]  Yi Zheng,et al.  Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease , 2017, Clinical Rheumatology.

[7]  G. Kitas,et al.  Platelets in rheumatoid arthritis: exploring the anti-inflammatory and antithrombotic potential of TNF inhibitors , 2016, Annals of the rheumatic diseases.

[8]  J. Sibilia,et al.  Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases , 2016, Saudi medical journal.

[9]  A. Maseri,et al.  Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis , 2016, Annals of the rheumatic diseases.

[10]  D. Lynch,et al.  An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features , 2015, European Respiratory Journal.

[11]  D. Dragosavac,et al.  Association of the immature platelet fraction with sepsis diagnosis and severity , 2015, Scientific Reports.

[12]  J. Hoffmann.  Reticulated platelets: analytical aspects and clinical utility , 2014, Clinical chemistry and laboratory medicine.

[13]  S. Krause,et al.  Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients , 2013, Clinical chemistry and laboratory medicine.

[14]  J. Hoffmann,et al.  Reference intervals of reticulated platelets and other platelet parameters and their associations. , 2013, Archives of pathology & laboratory medicine.

[15]  Georg Schett,et al.  The pathogenesis of rheumatoid arthritis. , 2011, The New England journal of medicine.

[16]  G. Kitas,et al.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications , 2011, Rheumatology International.

[17]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[18]  Cynthia S Crowson,et al.  Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. , 2010, Arthritis and rheumatism.

[19]  E. Grove,et al.  Immature platelets in patients with acute coronary syndromes , 2008, Thrombosis and Haemostasis.

[20]  M. Amengual,et al.  Reticulated platelets as a screening test to identify thrombocytopenia aetiology. , 2008, QJM : monthly journal of the Association of Physicians.

[21]  P. Bartels,et al.  Changes in platelet volume, morphology and RNA content in subjects treated with haemodialysis , 2008, Scandinavian journal of clinical and laboratory investigation.

[22]  M. Lenardo,et al.  The role of immune cells and cytokines in the pathogenesis of rheumatoid arthritis , 2006 .

[23]  M. A. van de Laar,et al.  Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[24]  K. Ohta,et al.  Pathophysiological significance of simultaneous measurement of reticulated platelets, large platelets and serum thrombopoietin in non‐neoplastic thrombocytopenic disorders , 1999, European journal of haematology.

[25]  I. Mackie,et al.  Reticulated platelets. , 1997, Platelets.

[26]  M. Prevoo,et al.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.